BioGaia Investor Relations Material
Latest events
Q1 2025
BioGaia
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from BioGaia
Access all reports
Segment Data
Access more data
Net sales by
Business area
Paediatrics
Adult health
Other
Expenses by
Financials
BioGaia AB develops and markets a wide range of probiotic products with documented health benefits. The company is focused on human health, animal health and the environment, and creates new benefits through the development of novel target groups and or applications. The company's current product portfolio includes Dysbiosis Treatment, Concept 2, Gastrointestinal Fortifier, Protectis, Nestum, Synbiome Defense, and Vi-sualize. Its products are used in various applications such as food supplement industry, animal health sector and human health sector.
Key slides for BioGaia
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
BIOG
Country
🇸🇪 Sweden